A Study of AZD3470, a PRMT5 Inhibitor, Given as Monotherapy and in Combination in Patients With MTAP Deficient Advanced/Metastatic Solid Tumors
מצבים רפואיים
Advanced Solid Tumors That Are MTAP Deficient
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Research Site, San Francisco, California, United States
Research Site, West Hollywood, California, United States
Research Site, New Haven, Connecticut, United States
Research Site, Baltimore, Maryland, United States
Research Site, Portland, Oregon, United States
Research Site, Pittsburgh, Pennsylvania, United States
Research Site, Providence, Rhode Island, United States
Research Site, Fairfax, Virginia, United States
Research Site, Melbourne, Australia
Research Site, Beijing, China
Research Site, Chengdu, China
Research Site, Shanghai, China
Research Site, Villejuif, France
Research Site, Chūōku, Japan
Research Site, Kashiwa, Japan
Research Site, Amsterdam, Netherlands
Research Site, Seoul, South Korea
Research Site, Seoul, South Korea
Research Site, Barcelona, Spain
Research Site, Madrid, Spain